Waypath Pharma LLC
Metairie, LA
- UEI
- WRM7JGHL7QT3
- CAGE
- 8SSK5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 217 Sena Dr, Metairie, LA 70005, USA
- Website
- waypathpharma.com
- Founded
- 2019
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| New anti-glioblastoma metabolic compounds with high potential for blood brain barrier penetration - glioblastomas are… | National Cancer Institute (NIH) | $900,000 |
SBA capabilities narrative
Waypath Pharma LLC is a company established in 2019 with the purpose of developing new and innovative anti cancer metabolic drugs for canines. These drugs are based on a new class of metabolically active molecules. All of these compounds are patent protected. These unique compounds enable the targeting and destruction of cancer by blocking energy metabolism at the level of mitochondrial repiration. Waypath Pharma LLC will primarily focun on treating and curing cancer in dogs.
Quick answers
Is Waypath Pharma LLC registered in SAM.gov?
Yes. Waypath Pharma LLC's SAM.gov registration is active through March 5, 2027.
What is Waypath Pharma LLC's most recent federal award?
Waypath Pharma LLC's most recent federal grant award is New anti-glioblastoma metabolic compounds with high potential for blood brain barrier penetration - glioblastomas are… (R41CA275433), from National Cancer Institute (NIH), on September 2, 2022.
On GovTribe
See Waypath Pharma LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors